Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study

WHO (2020) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) Available from www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed 30 Mar 2020

WHO (2020) Rolling updates on coronavirus disease (COVID-19). Available from www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Accessed 11 Apr 2020

WHO (2020) Coronavirus disease (COVID-19) pandemic. Available from www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 7 June 2020

Bragg F, Holmes MV, Iona A et al (2017) Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA 317(3):280–289. https://doi.org/10.1001/jama.2016.19720

Gregg EW, Cheng YJ, Srinivasan M et al (2018) Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391(10138):2430–2440. https://doi.org/10.1016/s0140-6736(18)30314-3

Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J (2016) Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol 4(2):148–158. https://doi.org/10.1016/s2213-8587(15)00379-4

Rao Kondapally Seshasai S, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841. https://doi.org/10.1056/NEJMoa1008862

Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A (2010) Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33(1):55–60. https://doi.org/10.2337/dc09-0880

Lepper PM, Ott S, Nuesch E et al (2012) Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 344:e3397. https://doi.org/10.1136/bmj.e3397

McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ (2005) The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 28(4):810–815. https://doi.org/10.2337/diacare.28.4.810

Yang JK, Feng Y, Yuan MY et al (2006) Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23(6):623–628. https://doi.org/10.1111/j.1464-5491.2006.01861.x

Alanazi KH, Abedi GR, Midgley CM et al (2020) Diabetes mellitus, hypertension, and death among 32 patients with MERS-CoV infection, Saudi Arabia. Emerg Infect Dis 26(1):166–168. https://doi.org/10.3201/eid2601.190952

Bode B, Garrett V, Messler J et al (2020) Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol:193229682092446. https://doi.org/10.1177/1932296820924469

Zhu L, She ZG, Cheng X et al (2020) Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 31(6):1068–1077.e3. https://doi.org/10.1016/j.cmet.2020.04.021

WHO (2020) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Available from www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117. Accessed 31 Mar 2020

National Health Commission of the People’s Republic of China (2020) Diagnosis and treatment plan of coronavirus disease 2019 (COVID-19) (trial version 6) Available from www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf. Accessed 31 Mar 2020 [document in Chinese]

WHO (2020) Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. Available from https://apps.who.int/iris/handle/10665/331446. Accessed 30 Mar 2020

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/s0140-6736(20)30183-5

Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179–c184. https://doi.org/10.1159/000339789

Schneider GT, Maier SAN (2020) Cerebrovascular accident. In: Weissbrod PA, Francis DO (eds) Neurologic and neurodegenerative diseases of the larynx. Springer, Cham, pp 215–228. https://doi.org/10.1007/978-3-030-28852-5_18

Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3

Ewig S, Bauer T, Richter K et al (2013) Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups. Eur Respir J 41(4):917–922. https://doi.org/10.1183/09031936.00065212

Ewig S, Birkner N, Strauss R et al (2009) New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64(12):1062–1069. https://doi.org/10.1136/thx.2008.109785

Shi H, Han X, Jiang N et al (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 20(4):425–434. https://doi.org/10.1016/s1473-3099(20)30086-4

Yang X, Yu Y, Xu J et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475–481. https://doi.org/10.1016/s2213-2600(20)30079-5

Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med https://doi.org/10.1001/jamainternmed.2020.0994

Bauer TT, Ewig S, Marre R, Suttorp N, Welte T (2006) CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260(1):93–101. https://doi.org/10.1111/j.1365-2796.2006.01657.x

Bar-Or D, Rael LT, Madayag RM et al (2019) Stress hyperglycemia in critically ill patients: insight into possible molecular pathways. Front Med (Lausanne) 6:54. https://doi.org/10.3389/fmed.2019.00054

Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN (2005) Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 33(12):2772–2777. https://doi.org/10.1097/01.ccm.0000189741.44071.25

Burcelin R, Amar J (2015) Diabetes: antibiotics or prodiabetics? Nat Rev Endocrinol 11(7):385–386. https://doi.org/10.1038/nrendo.2015.75

Johns EC, Reynolds RM (2019) Topical glucocorticoids and risk of type 2 diabetes mellitus. Nat Rev Endocrinol 15(7):379–380. https://doi.org/10.1038/s41574-019-0212-8

Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367. https://doi.org/10.1056/NEJMoa011300

Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354(5):449–461. https://doi.org/10.1056/NEJMoa052521

Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297. https://doi.org/10.1056/NEJMoa0810625

Stapleton RD, Heyland DK (2020) UpToDate: glycemic control and intensive insulin therapy in critical illness. Available from www.uptodate.com/contents/glycemic-control-and-intensive-insulin-therapy-in-critical-illness. Accessed 30 Mar 2020